相关实验视频

Updated: Jul 11, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

122

维内托克拉克斯在复发/耐药多发性骨髓瘤患者的疗效和安全性:一个元分析

Xiaohui Gao1, Hui Zeng2, Xiaoyan Zhao2

  • 1Departments of Pediatrics, The Affiliated Hospital of Jiaxing University, Jiaxing, 314000, Zhejiang, China.

BMC cancer
|November 4, 2023
PubMed
概括

威尼托克拉克斯在治疗复发性/耐药性多发性骨髓瘤 (RRMM) 中表现出显著的疗效. 这项对7项试验的分析显示,在RRMM患者中,基于venetoclax的疗法具有有利的响应率和可控的副作用.

关键词:
不良事件是不良事件.有效性 有效性.进行元分析分析.多发性骨髓瘤是多发性骨髓瘤的一种.威尼托克拉克斯 (Venetoclax) 是一个属于威尼托克拉克斯的地区.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.4K
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

2.4K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K